losartan-potassium and artenimol

Malaria parasites induce morphological and biochemical changes in the membranes of parasite-infected red blood cells (iRBCs) for propagation. Artemisinin combination therapies are the first-line antiplasmodials in countries of endemicity. However, the mechanism of action of artemisinin is unclear, and drug resistance decreases long-term efficacy. To understand whether artemisinin targets or interacts with iRBC membrane proteins, this study investigated the molecular changes caused by dihydroartemisinin (DHA), an artemisinin derivative, in Plasmodium falciparum 3D7 using a combined transcriptomic and membrane proteomic profiling approach. Optical microscopy and scanning electron microscopy showed that DHA can cause morphological variation in the iRBC membrane. We identified 125 differentially expressed membrane proteins, and functional analysis indicated structural molecule activity and protein export as key biological functions of the two omics studies. DHA treatment decreased the expression of

Topics: Antimalarials; Artemisinins; Cell Membrane; Erythrocytes; Erythropoietin; Gene Expression; Gene Expression Profiling; Membrane Proteins; Microscopy, Electron, Scanning; Peptides, Cyclic; Plasmodium falciparum; Proteomics; Protozoan Proteins; Transcriptome